|
1003
|
Vaxelis
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1004
|
Boostrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1005
|
Infanrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1006
|
Infanrix-IPV+Hib vaccine
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1007
|
Infanrix/Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NCT00696423
|
|
1008
|
Infanrix-IPV
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1009
|
Pentacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
|
1010
|
Daptacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NCT00258895
|
|
1011
|
Tdvax
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
MassBiologics
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1012
|
Quadracel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1013
|
Adacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1014
|
Pediarix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1015
|
Kinrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
18980534
|
NA
|
|
1016
|
Tenivac
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1017
|
Decavac
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1018
|
DT Generic
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1019
|
DT Polio Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
21441781
|
NA
|
|
1020
|
Infanrix hexa
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1021
|
Hexaxim
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pateur
|
Approved
|
Intramuscular
|
NA
|
NCT02428491
|
|
1022
|
Shan-5
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Healthcare India Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1023
|
Actacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1024
|
Quinvaxem inj.
|
Diphtheria
|
Corynebacterium diphtheriae
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
|
1025
|
EasyFive-TT
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Panacea Biotech Ltd.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1026
|
Pentaxim
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd.
|
Approved
|
Intramuscular
|
21749196
|
NA
|
|
1027
|
Pediacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
21999652
|
NA
|
|
1028
|
Tripacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1029
|
Tetravac or Tetravac Acellulaire
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1030
|
Boostrix Polio
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1031
|
Td-pur
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Novartis vaccine Diagnostics GmbH & Co. KG.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1032
|
REPEVAX
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1033
|
Adacel Polio
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1034
|
Tripedia
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur, Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1035
|
Td Polio Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1036
|
Td Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1037
|
Diphtheria and Tetanus Toxoids Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1244
|
BK1310
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT03891758
|
|
1245
|
Zilbrix-Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18352853
|
NCT00473668
|
|
1246
|
Tritanrix-HepB/ Hiberix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00473668
|
|
1247
|
Tritanrix-HepB/Hib-MenAC
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00136604
|
|
1248
|
GSK2202083A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01171989
|
|
1249
|
HR5I
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00551629
|
|
1250
|
Ravexis
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00447525
|
|
1251
|
DT Polio
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00447525
|
|
1252
|
Tritanrix-HepB/Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00313911
|
|
1253
|
V441
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00092469
|
|
1254
|
GSK323527A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00332566
|
|
1255
|
GSK217744
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01453998
|
|
1256
|
DTaP-IPVvero
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1257
|
DTaP-IPVmkc
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Statens Serum Institut
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT00655148
|
|
1258
|
GSK2036874A
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01106092
|
|
1259
|
Eupenta Inj.
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
LG Chem
|
Clinical - Phase 4
|
NA
|
NA
|
NCT04056728
|
|
1260
|
TETRAXIM
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01031303
|
|
1261
|
SHAN6
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04429295
|
|
1262
|
BR-TD-1001
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Boryung Biopharma Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
26091286
|
NCT04618939
|
|
1263
|
Infanrix+Hib
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
18251697
|
NCT01449812
|
|
1264
|
Ditanrix Adult
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01294605
|
|
1265
|
GC3111
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Green Cross Corporation
|
Clinical - Phase 2
|
Intramuscular
|
34641798
|
NCT04238975
|
|
1266
|
Squarekids
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
|
Clinical - Discontinued
|
Subcutaneous
|
NA
|
NCT02907216
|
|
1267
|
COVAXIS
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00304265
|
|
1268
|
BK1301
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02118961
|
|
1269
|
DTBIK
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02118961
|
|
1270
|
diTekiBooster
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Swedish Institute for Infectious Disease Control
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT00870350
|
|
1271
|
SP306 (in Japan)
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02089347
|
|
1272
|
HEXAVAC
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01457547
|
|
1273
|
Tetrabik
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT01926015
|
|
1274
|
Td-Rix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Combination
|
GlaxoSmithKline
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT01262924
|